TY - JOUR
T1 - An unusual complication following transarterial chemoembolization: Acute myocardial infarction
AU - Lai, Yi-Liang
AU - Chang, Wei-Chou
AU - Kuo, Wu-Hsien
AU - Huang, Tien-Yu
AU - Chu, Heng-Cheng
AU - Hsieh, Tsai-Yuan
AU - Chang, Wei-Kuo
N1 - Export Date: 22 March 2016
CODEN: CARAD
通訊地址: Chang, W.-K.; Department of Internal Medicine, National Defense Medical Center, Tri-Service General Hospital, 325 Cheng-Kung Road, Sec. 2, Neihu, Taipei, Taiwan; 電子郵件： [email protected]
化學物質/CAS: doxorubicin, 23214-92-8, 25316-40-9; iodinated poppyseed oil, 8001-40-9, 8002-46-8, 8006-56-2, 8006-57-3; pethidine, 28097-96-3, 50-13-5, 57-42-1; Doxorubicin, 23214-92-8; Iodized Oil, 8001-40-9
商標： adriamycin; demerol
參考文獻: Bosch, F.X., Ribes, J., Diaz, M., Cleries, R., Primary liver cancer: Worldwide incidence and trends (2004) Gastroenterology, 127 (SUPPL.), pp. S5-S16. , DOI 10.1053/j.gastro.2004.09.011, PII S0016508504015902; Bruix, J., Sherman, M., Management of hepatocellular carcinoma (2005) Hepatology, 42 (5), pp. 1208-1236. , DOI 10.1002/hep.20933; Yamada, R., Sato, M., Kawabata, M., Hepatic artery embolization in 120 patients with unresectable hepatoma (1983) Radiology, 148 (2), pp. 397-401. , 1:STN:280:DyaL3s3kvVWhsA%3D%3D 6306721; Liapi, E., Georgiades, C.C., Hong, K., Geschwind, J.-F.H., Transcatheter Arterial Chemoembolization: Current Technique and Future Promise (2007) Techniques in Vascular and Interventional Radiology, 10 (1), pp. 2-11. , DOI 10.1053/j.tvir.2007.08.008, PII S1089251607000704, Interventional Oncology - Part 1: Hepatic Interventions; Lau, W.Y., Yu, S.C.H., Lai, E.C.H., Leung, T.W.T., Transarterial chemoembolization for hepatocellular carcinoma (2006) Journal of the American College of Surgeons, 202 (1), pp. 155-168. , DOI 10.1016/j.jamcollsurg.2005.06.263, PII S1072751505009890; Ahrar, K., Gupta, S., Hepatic artery embolization for hepatocellular carcinoma: Technique, patient selection, and outcomes (2003) Surgical Oncology Clinics of North America, 12 (1), pp. 105-126. , DOI 10.1016/S1055-3207(02)00089-3, PII S1055320702000893; Kokudo, N., Makuuchi, M., Current role of portal vein embolization/hepatic artery chemoembolization (2004) Surgical Clinics of North America, 84 (2), pp. 643-657. , DOI 10.1016/j.suc.2003.12.004, PII S0039610903002408; Del Pozo, A.C., Lopez, P., Management of hepatocellular carcinoma (2007) Clinics in Liver Disease, 11 (2), pp. 305-321. , DOI 10.1016/j.cld.2007.04.007, PII S1089326107000220, Liver Transplantation; Kothary, N., Weintraub, J.L., Susman, J., Rundback, J.H., Transarterial Chemoembolization for Primary Hepatocellular Carcinoma in Patients at High Risk (2007) Journal of Vascular and Interventional Radiology, 18 (12), pp. 1517-1526. , DOI 10.1016/j.jvir.2007.07.035, PII S105104430701113X; Yen, F.S., Wu, J.C., Kuo, B.I., Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis (1995) J Gastroenterol Hepatol, 10 (3), pp. 237-240. , 10.1111/j.1440-1746.1995.tb01086.x 1:STN:280:DyaK28%2FitlCgsw%3D%3D 7548796; Chung, J.W., Park, J.H., Han, J.K., Hepatic tumors: Predisposing factors for complications of transcatheter oily chemoembolization (1996) Radiology, 198 (1), pp. 33-40. , 1:STN:280:DyaK287itlWguw%3D%3D 8539401; White, H.D., Chew, D.P., Acute myocardial infarction (2008) Lancet, 372 (9638), pp. 570-584. , 10.1016/S0140-6736(08)61237-4 1:CAS:528:DC%2BD1cXpvFKgsLg%3D 18707987; Calvo-Romero, J.M., Fernández-Soria-Pantoja, R., Arrebola-Garcia, J.D., Ischemic heart disease associated with vincristine and doxorubicin chemotherapy (2001) Ann Pharmacother, 35 (11), pp. 1403-1405. , 10.1345/aph.10358 1:STN:280:DC%2BD3MnnslKitg%3D%3D 11724093; McCord, J.M., Oxygen-derived free radicals in postischemic tissue injury (1989) N Engl J Med, 312, pp. 159-163; Lu, W., Li, Y.H., He, X.F., Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization (2008) Cardiovasc Interv Radiol, 31 (6), pp. 1133-1140. , 10.1007/s00270-008-9379-4; Kasugai, H., Kojima, J., Tatsuta, M., Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil (1989) Gastroenterology, 97 (4), pp. 965-971. , 1:STN:280:DyaL1MznvVKktw%3D%3D 2550311
PY - 2010
Y1 - 2010
N2 - Transarterial chemoembolization has been widely used to treat unresectable hepatocellular carcinoma. Various complications have been reported, but they have not included acute myocardial infarction. Acute myocardial infarction results mainly from coronary artery occlusion by plaques that are vulnerable to rupture or from coronary spasm, embolization, or dissection of the coronary artery. It is associated with significant morbidity and mortality. We present a case report that describes a patient with hepatocellular carcinoma who underwent transarterial chemoembolization and died subsequently of acute myocardial infarction. To our knowledge, there has been no previous report of this complication induced by transarterial chemoembolization for hepatocellular carcinoma. This case illustrates the need to be aware of acute myocardial infarction when transarterial chemoembolization is planned for the treatment of hepatocellular carcinoma, especially in patients with underlying coronary artery disease. © 2009 Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
AB - Transarterial chemoembolization has been widely used to treat unresectable hepatocellular carcinoma. Various complications have been reported, but they have not included acute myocardial infarction. Acute myocardial infarction results mainly from coronary artery occlusion by plaques that are vulnerable to rupture or from coronary spasm, embolization, or dissection of the coronary artery. It is associated with significant morbidity and mortality. We present a case report that describes a patient with hepatocellular carcinoma who underwent transarterial chemoembolization and died subsequently of acute myocardial infarction. To our knowledge, there has been no previous report of this complication induced by transarterial chemoembolization for hepatocellular carcinoma. This case illustrates the need to be aware of acute myocardial infarction when transarterial chemoembolization is planned for the treatment of hepatocellular carcinoma, especially in patients with underlying coronary artery disease. © 2009 Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
KW - Acute myocardial infarction
KW - Hepatocellular carcinoma
KW - Transarterial chemoembolization
KW - doxorubicin
KW - gelfoam
KW - iodinated poppyseed oil
KW - pethidine
KW - abdominal pain
KW - acute heart infarction
KW - adult
KW - anorexia
KW - article
KW - case report
KW - cause of death
KW - chemoembolization
KW - cold sweat
KW - dyspnea
KW - hepatic artery
KW - human
KW - liver cell carcinoma
KW - male
KW - priority journal
KW - ST segment elevation
KW - thorax pain
KW - tumor thrombus
KW - weight reduction
KW - Arterial Occlusive Diseases
KW - Carcinoma, Hepatocellular
KW - Chemoembolization, Therapeutic
KW - Cholecystitis
KW - Coronary Disease
KW - Diabetes Mellitus, Type 2
KW - Doxorubicin
KW - Fatal Outcome
KW - Hepatic Artery
KW - Hepatitis B, Chronic
KW - Humans
KW - Iodized Oil
KW - Liver Neoplasms
KW - Male
KW - Middle Aged
KW - Myocardial Infarction
U2 - 10.1007/s00270-009-9683-7
DO - 10.1007/s00270-009-9683-7
M3 - Article
SN - 0174-1551
VL - 33
SP - 196
EP - 200
JO - CardioVascular and Interventional Radiology
JF - CardioVascular and Interventional Radiology
IS - 1
ER -
